基本信息
views: 67
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Almeida-Porada is a Professor of Regenerative Medicine at Wake Forest Institute for Regenerative Medicine, Affiliate Faculty Member, Molecular Medicine, Physiology and Pharmacology Wake Forest School of Medicine and Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences
Dr. Almeida-Porada received her medical degree in 1985 from the University of Porto, Portugal. She completed her residency in 1987 and fellowship in Hematology/Transfusion Medicine in 1994, and obtained her Ph.D. in Pathology from the same University in 1995. She was a fellow at the University of Connecticut Health Center and at the University of Nevada, Reno School of Medicine. She became faculty at the University of Nevada, Reno in 1999. In 2001 she joined the Department of Animal Biotechnology at the same Institution, where she was a Professor and the Director of Graduate Studies. In 2006 she was inducted into Phi Beta Delta. She has been a member of several NIH study sections, she serves/ed as an Editor, or on the Editorial Boards of several scientific journals, and she is the 2015 president elect of NCTERMS. She is a founding member of the Perinatal Stem Cell Society and the Co-founder of the Fetal Transplantation and Immunology Society. Dr. Almeida-Porada has authored more than 200 scientific works including papers, abstracts, and book chapters.
Her contributions to the field of hematopoiesis include defining novel human hematopoietic stem/progenitor cell (HSC) phenotypes and demonstrating the importance of bone marrow-derived stromal populations in expansion of cord-blood derived HSC, and as enhancers of HSC engraftment in a pre-natal setting. Furthermore, by using a fetal sheep model as a tool to study hematopoietic development and engraftment/differentiation of putative human stem cells, Dr. Almeida-Porada showed the ability of human HSC and marrow-derived stromal populations to reprogram in vivo and differentiate to cells of other dermal derivations. She also used genetically engineered stromal cells to deliver therapeutic genes and correct diseases such as Hemophilia A, and developed means to overexpress specific proteins that enhance the immunomodulatory potential and allow increased engraftment of stromal cells.
Research Interests
Papers共 9 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer researchno. 7_Supplement (2023): 184-184
Quan D. M. Pham, Sharon M. Thomson, Burk N. Schaible,Kevin D. Mills,Anthony Atala,Christopher D. Porada,Graca Almeida-Porada
Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia (2021): S80-S81
Bloodno. 12 (1997): 5002-5012
Author Statistics
#Papers: 123
#Citation: 4749
H-Index: 29
G-Index: 68
Sociability: 6
Diversity: 2
Activity: 8
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn